Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Director | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,899 |
Reported balance
After 2026-02-11 transaction · row 1
1 source rowRow 1 · 2026-02-11 · Grant · Acquired 870 · Balance 6,899 F1: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005433 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,899 F1 · shares: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004800 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,029 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restriction of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 20:41 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013505 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,029 F1 · shares: Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restriction of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007131 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007131 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,049 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006025 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006025 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,509 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:07 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,747 | $0.00 Strike: $138.07 | $0.00 |
DisclosureSEC source: 0001140361-22-005094 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,787 Underlying: Common Stock · 1,747 shares Expires 2032-02-11 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:07 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005094 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,979 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:52 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,124 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-005118 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,040 Underlying: Common Stock · 2,124 shares Expires 2031-02-11 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:52 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005118 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,470 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2.946 | $0.00 Strike: $111.94 | $0.00 |
DisclosureSEC source: 0001140361-20-003483 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,916 Underlying: Common Stock · 2.946 shares Expires 2030-02-13 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 15:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003483 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,880 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 17:07 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,587 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003336 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,972 Underlying: Common Stock · 3,587 shares Expires 2029-02-13 F2 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 17:07 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003336 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,273 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 17:26 UTC | BALCHEM CORP BCPC · Entity 3839 | PurchaseCommon Stock | 650 | $89.11 | $57,921.50 |
DisclosureSEC source: 0001140361-18-043054 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 22:54 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,383 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-18-009150 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,383 Underlying: Common Stock · 3,383 shares Expires 2028-02-15 F2 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 22:54 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 845 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009150 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.